ReCor Responds to European Society of Hypertension's (ESH) Updated Guidelines for Management of Arterial Hypertension

Treating hypertension is complex, and European guidelines reinforce the safety and effectiveness of renal denervation as a treatment option to improve hypertension controlPALO ALTO, Calif.--(BUSINESS WIRE)--ReCor Medical, Inc. (“ReCor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Device...

Related Keywords

Tokyo ,Japan ,Poland ,France ,United States ,Lurbe ,Aquitaine ,Jordan ,Paris ,France General ,Polonia ,Lara Barghout ,Georges Pompidou ,Michel Azizi ,Otsuka Medical Devices Co Ltd ,European Union ,International Society Of Hypertension ,Recor Medical Inc ,European Renal Association ,European Society Of Hypertension ,Drug Administration ,Otsuka Holdings Co Ltd ,Kreutz Co ,Tokyo Stock Exchange ,Authors Task Force Members ,Recor Medical ,European Society ,European Meeting ,Arterial Hypertension ,International Society ,Paris Cit ,Cor Medical ,Ultrasound Renal Denervation ,Paradise Ultrasound ,Recor President ,Systems Devices Panel ,Medical Devices Advisory Committee ,Palo Alto ,Paradise Ultrasound Renal Denervation ,Paradise System ,Global Paradise System ,Medical Devices ,Task Force Members ,Task Force ,Hypertension Endorsed ,